Business
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and
About this update from Azenta, Inc.
[{"type":"text","content":"Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and SIRQC Clinical Registries\nBURLINGTON, Mass., June 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Crohn's & Colitis Foundation (the \"Foundation\") as its sample management services provider for two of its large-scale prospective research cohorts, CAPTURE IBD and IBD SIRQC, which investigate pediatric and surgical care for Crohn's disease and ulcerative colitis. Azenta will provide sample management services, including sample processing, analysis, logistics, and storage for these pivotal studies.\nThese studies are part of the Foundation's IBD Plexus® research ecosystem and data platform that redefines how the research community studies Crohn's disease and ulcerative colitis to advance next-generation discoveries and novel therapies. The platform offers a rich research ecosystem for academic and life science researchers, providing prospective, longitudinal, and well-phenotyped data linked to biosamples to accelerate answering high-impact, patient-prioritized questions, and drive a revolutionary approach toward faster cures.\nCAPTURE IBD (Cohort for Pediatric Translational and Clinical Research in Inflammatory Bowel Disease) is a multi-center, longitudinal study designed to advance precision medicine in pediatric IBD. CAPTURE is looking to enroll several thousand pediatric patients at 12 participating sites in the United States.\nIBD SIRQC (Surgical Innovation, Research, and Quality Collaborative) is the Foundation's first-ever surgical research initiative designed as a longitudinal surgical cohort that will track long-term surgery outcomes including post-procedure complications and disease recurrence. SIRQC is looking to enroll 5,000 patients at 9 participating sites in the United States.\n\"The integration of novel pediatric and surgical data and biosamples into the IBD Plexus platform is critical to advance understanding of the complexity of IBD and develop precision medicine strategies,\" said Angela Dobes, Senior Vice President, IBD Plexus, Crohn's & Colitis Foundation. \"We selected Azenta to support our CAPTURE and SIRQC research initiatives because of their high-quality, centralized sample management services and strong...